Prateek Bhardwaj

Prateek Bhardwaj works with Prof. Ranjit S. Bindra’s research group as a Postdoctoral Associate in the Department of Therapeutic Radiology, Yale School of Medicine. After obtaining a Ph.D. in Nanomedicine, he is now keenly interested in developing personalized medicine for leukemia by understanding and exploiting the synthetic lethal interactions between the genes involved in DNA damage response. Pertaining to his doctoral research on developing smart biomaterial-based theranostic nano-platforms and hydrogels for effective site-specific chemoradiotherapy of superficially accessible and deep-seated malignancies like Oral cancer and Triple-negative breast cancer respectively, he has been granted a patent and published several peer-reviewed research and review articles in esteemed international journals like Nanoscale, Journal of Controlled Release, Biomaterials, Acta Biomaterialia, and Biomacromolecules. He strongly believes that amalgamating basic science with nanomedicine can bring a revolutionary improvement in existing healthcare technologies by discovering next-generation therapeutics along with their effective delivery for better patient compliance.